Corcept Therapeutics Incorporated shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $48M | 1.0M | 46.28 |
| 2024-06-30 | $32M | 973k | 32.49 |
| 2024-03-31 | $24M | 934k | 25.19 |
| 2023-12-31 | $29M | 900k | 32.48 |
| 2023-09-30 | $24M | 861k | 27.25 |
| 2023-06-30 | $19M | 844k | 22.25 |
| 2023-03-31 | $19M | 890k | 21.66 |
| 2022-12-31 | $18M | 890k | 20.31 |
| 2022-09-30 | $21M | 823k | 25.64 |
| 2022-06-30 | $19M | 815k | 23.78 |
| 2022-03-31 | $18M | 786k | 22.52 |
| 2021-12-31 | $14M | 680k | 19.80 |
| 2021-09-30 | $15M | 765k | 19.68 |
| 2021-06-30 | $17M | 766k | 22.00 |
| 2021-03-31 | $19M | 790k | 23.79 |
| 2020-12-31 | $20M | 764k | 26.16 |
| 2020-09-30 | $13M | 750k | 17.41 |
| 2020-06-30 | $13M | 766k | 16.82 |
| 2020-03-31 | $8.2M | 691k | 11.89 |
| 2019-12-31 | $8.3M | 687k | 12.10 |
| 2019-09-30 | $8.5M | 600k | 14.14 |
| 2019-06-30 | $6.6M | 592k | 11.15 |
| 2019-03-31 | $6.8M | 582k | 11.74 |
| 2018-12-31 | $7.5M | 562k | 13.36 |
| 2018-09-30 | $7.9M | 562k | 14.02 |
| 2018-06-30 | $7.9M | 502k | 15.72 |
| 2018-03-31 | $8.1M | 491k | 16.45 |
| 2017-12-31 | $8.7M | 481k | 18.06 |
| 2017-09-30 | $8.0M | 414k | 19.30 |
| 2017-06-30 | $4.4M | 371k | 11.80 |
| 2017-03-31 | $3.7M | 340k | 10.96 |
| 2016-12-31 | $2.3M | 321k | 7.26 |
| 2016-09-30 | $1.8M | 279k | 6.50 |
| 2016-06-30 | $640k | 117k | 5.47 |
| 2016-03-31 | $405k | 87k | 4.68 |
| 2015-12-31 | $431k | 87k | 4.98 |
| 2015-09-30 | $326k | 87k | 3.77 |
| 2015-06-30 | $520k | 87k | 6.01 |
| 2015-03-31 | $384k | 68k | 5.61 |
| 2014-12-31 | $206k | 68k | 3.01 |
| 2014-09-30 | $184k | 68k | 2.69 |
| 2014-06-30 | $192k | 68k | 2.81 |
| 2014-03-31 | $299k | 68k | 4.37 |
| 2013-12-31 | $221k | 68k | 3.23 |
| 2013-09-30 | $111k | 68k | 1.62 |
| 2013-06-30 | $122k | 68k | 1.78 |
| 2013-03-31 | $131k | 68k | 1.92 |
| 2012-12-31 | $98k | 68k | 1.43 |
| 2012-09-30 | $189k | 68k | 2.76 |
| 2012-06-30 | $236k | 55k | 4.29 |
| 2012-03-31 | $223k | 55k | 4.05 |
| 2011-12-31 | $189k | 55k | 3.44 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated